Caplin Point Laboratories Ltd Stock NSE India S.E.
Stocks
INE475E01018
Pharmaceuticals
|
End-of-day quote
NSE India S.E.
|
||
| - INR | - |
|
| Aug. 14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| Aug. 12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 192B 2B 1.73B 1.62B 1.48B 2.78B 2.82B 19.02B 7.46B 95.99B 7.52B 7.36B 319B | P/E 2026 |
17.9x | P/E 2027 * | 26x |
|---|---|---|---|---|---|
| Enterprise Value | 192B 2B 1.73B 1.62B 1.48B 2.78B 2.82B 19.02B 7.46B 95.99B 7.52B 7.36B 319B | EV / Sales 2026 |
5.23x | EV / Sales 2027 * | 7.66x |
| Free-Float |
26.39% | Yield 2026 * |
-
| Yield 2027 * | 0.16% |
Last Transcript: Caplin Point Laboratories Ltd
| Manager | Title | Age | Since |
|---|---|---|---|
Sridhar Ganesan
CEO | Chief Executive Officer | 71 | 2015-03-27 |
D. Muralidharan
DFI | Director of Finance/CFO | - | 2016-02-18 |
Anto V.
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2010-01-26 | |
| Director/Board Member | - | 2025-11-04 | |
Sridhar Ganesan
BRD | Director/Board Member | 71 | 2015-03-27 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.49% | -3.24% | +14.66% | +64.56% | 48.43B | |
| -0.12% | -5.43% | +52.28% | +115.90% | 39.72B | |
| -1.28% | -2.21% | -8.47% | +15.11% | 12.25B | |
| -0.33% | +1.55% | +14.43% | +72.12% | 11.84B | |
| -0.58% | -0.77% | +29.90% | +141.59% | 9.06B | |
| 0.00% | +1.64% | +22.99% | +39.94% | 7.57B | |
| -0.88% | +1.18% | +40.97% | -13.86% | 7.18B | |
| +0.46% | +2.19% | +13.91% | +192.06% | 6.84B | |
| +0.63% | -2.53% | -30.10% | +23.84% | 5.77B | |
| Average | -0.51% | +0.25% | +16.73% | +72.36% | 16.52B | |
| Weighted average by Cap. | -1.01% | -1.22% | +23.64% | +78.75% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 21.28B 223M 192M 180M 164M 309M 313M 2.11B 828M 10.66B 836M 817M 35.46B | 25.01B 262M 226M 212M 193M 363M 368M 2.48B 973M 12.53B 982M 961M 41.68B |
| Net income | 6.16B 64.45M 55.64M 52.2M 47.54M 89.39M 90.63M 612M 240M 3.09B 242M 237M 10.27B | 7.37B 77.07M 66.54M 62.42M 56.85M 107M 108M 732M 287M 3.69B 289M 283M 12.28B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
